Content

Rice-Based Expression System to Produce Recombinant, Scalable, and Sustainable Raw Materials for Biomanufacturing

Part of the BTEC Fall 2024 Seminar Series

Friday, Sept. 20, 2024
10:40–11:30 a.m. EST
Zoom: go.ncsu.edu/btec_seminar

InVitria, Inc. is a biotechnology company founded in 2008 with locations in Kansas, Boston, Denver, The Netherlands, & Munich. ExpressTec, InVitria’s core technology, is an innovative plant-based protein expression system that revolutionizes the production of recombinant proteins for biotechnology and life science applications. This technology utilizes rice plants as bioreactors, harnessing their natural ability to synthesize complex proteins efficiently and at scale. The ExpressTec platform offers several key advantages, including high yield, producing recombinant proteins at significantly higher levels compared to other plant-based systems. Additionally, it ensures safety by being free from animal or human components, thereby eliminating risks associated with pathogens or contaminants. Scalability is another benefit, as rice cultivation allows for virtually unlimited production capacity at a lower cost than traditional methods. The versatility of ExpressTec enables the production of a wide range of proteins, including multi-subunit molecules, monoclonal antibodies, and enzymes. Furthermore, this system contributes to sustainability with a reduced carbon footprint compared to conventional bioreactor-based production methods. InVitria leverages ExpressTec to manufacture high-quality recombinant proteins and supplements for various applications, including cell and gene therapy, vaccine production, and biologic formulation. This technology addresses critical needs in the biopharmaceutical industry for safer, more consistent, and cost-effective protein production.

Speakers

Jacob Weber, Ph.D.
Director of Process Development
InVitria

Elliot Renft
Director of Product Applications
InVitria